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The trafficking of nutrient transporters is highly regu-
lated and controlled by a variety of signal transduction
pathways. A recent study by Gao and Kaiser (2006) in
Nature Cell Biology demonstrates a role for a novel
GTPase-containing complex that allows the amino
acid permease Gap1 to recycle out of late endosomal
compartments. This complex is likely to play critical
roles in allowing animal cells to mobilize their nutrient
transporters in response to metabolic demands.
The yeast S. cerevisiae has evolved an array of sophis-
ticated mechanisms to achieve nutrient homeostasis.
Studying these processes has led to the discovery of
fascinating mechanisms that link nutrient sensing and
target of rapamycin (TOR)-dependent signaling path-
ways to transcriptional, translational, and membrane
trafficking responses (Wullschleger et al., 2006).
The behavior of general amino acid permease (Gap1)
exemplifies some of the membrane trafficking mecha-
nisms that contribute to nutrient homeostasis in yeast
and is likely to be an important model for analogous pro-
cesses in animal cells (Magasanik and Kaiser, 2002).
Gap1 is a low specificity transporter that can allow the
uptake of a wide variety of amino acids and derivatives.
In a medium where nitrogen source is limited, GAP1
transcription is induced and Gap1 protein is sent to
the cell surface, where it is stable and active. In a rich
medium where amino acids are plentiful, Gap1 is not
used. Instead, GAP1 transcription is repressed and
the trafficking of Gap1 transporter is dramatically al-
tered. In this situation, when newly synthesized Gap1
reaches the TGN, it is not sent to the cell surface and
instead it becomes ubiquitinated and diverted directly
to endosomes. At endosomes, ubiquitinated Gap1 is
sorted into multivesicular bodies (MVB) for eventual
degradation in the vacuole/lysosome.
Now, Minggeng Gao and Chris Kaiser have defined an
additional trafficking step for Gap1 that involves recy-
cling from endosomes back to the cell surface (Gao
and Kaiser, 2006). This sorting step competes against
sorting to the MVB and is mediated by a protein
complex dubbed the GSE complex (Gap1 sorting from
endosomes), which is virtually identical to the EGO
complex defined in other studies (Dubouloz et al.,
2005). Importantly, Gao and Kaiser show that the GSE-
dependent recycling route plays a critical physiological
role in supplying Gap1 to the cell surface at ‘‘intermedi-
ate’’ levelsofnitrogen, as loss ofGSE results indecreased
levels of Gap1, presumably due to increased flux to the
vacuole for degradation.
Gao and Kaiser identified the GSE complex and the
recycling route that it controls using a genetic screen
looking for loss of Gap1 activity at the cell surface.
This screen found two related GTPases, Gtr1 and Gtr2,that were required to sustain Gap1 levels at the cell
surface. Previous studies showed that Gtr1 and Gtr2
interact with two other proteins (Ego1/Meh1/Gse2 and
Ego3/Slm4/Gse1), and further biochemical experiments
from Gao and Kaiser found a fifth interacting protein,
Ltv1, to define a functional GSE complex. The GSE com-
plex is localized to late endosomal and vacuolar mem-
branes, and assembly and membrane recruitment of
GSE depends most strongly on the Ego1/Meh1/Gse1
component, which is both myristoylated and palmitoy-
lated (Dubouloz et al., 2005; Gao and Kaiser, 2006; Gao
et al., 2005).
Two key experiments support the idea that GSE sorts
Gap1 in late endosomes rather than other locations
such as the TGN. First, loss of GSE did not prevent
Gap1 routing to the cell surface directly from the TGN.
Thus, when nutritional conditions were favorable for
Gap1 secretion or when the ubiquitin-dependent path-
way that diverts Gap1 directly from the TGN to endo-
somes was blocked, Gap1 was delivered to the plasma
membrane even in the absence of GSE function. The
second experiment followed the fate of a population
of Gap1 that had been trapped on late endosomes. Us-
ing a class E vacuolar protein sorting mutant (vps27D)
that accumulates Gap1 in a large prevacuolar/late
endosomal compartment, Gao and Kaiser first drove
Gap1 into late endosomes and then followed subse-
quent delivery of Gap1 to the plasma membrane when
cells were shifted to nitrogen-poor conditions that favor
delivery and stabilization of Gap1 at the cell surface.
When the GSE complex was present, Gap1 readily ap-
peared at the cell surface; however, loss of any of the
GSE components blocked the mobilization of Gap1
from endosomes to the cell surface. Remarkably, GSE-
dependent movement of Gap1 from endosomes did not
require activity of other protein complexes that catalyze
other recycling steps (e.g., VFT, Retromer, and HOPS),
and loss of GSE did not perturb recycling of other late
Golgi components from endosomes. The specificity of
the GSE complex for Gap1 is partly explained by the
observation that it binds to Gap1 and this binding is
sensitive to mutations within the Gap1 C-terminal tail.
The interaction between Gap1 and GSE is important,
as mutations in Gap1 that diminish GSE binding also
diminish Gap1 presence at the cell surface. Thus, GSE
defines a specific recycling pathway out of late endo-
somes that is taken by a subset of proteins.
One intriguing aspect of the GSE complex is the
function of the two related yet functionally opposing
GTPases, Gtr1 and Gtr2. When locked into a GTP bound
conformation, Gtr1 is active in promoting Gap1 recycling
to the cell surface and can even suppress loss of other
GSE components. By contrast, the GTP-locked mutant
of Gtr2 has the opposite effect and inhibits delivery of
Gap1 to the cell surface. The presence of opposing
GTPases in the GSE complex provides ample opportu-
nity for the cell to regulate GSE function. Elucidation
of the GAPs and GEFs involved should provide impor-
tant insights into how GSE activity is controlled. One
Previews
7prediction is that the activity of GSE is tightly integrated
with the TOR kinase pathway. The nutrient responsive
TOR kinase pathway plays a key role in regulating the
sorting of amino acid transporters (Wullschleger et al.,
2006). Furthermore, cells lacking various GSE compo-
nents are hypersensitive to inhibition of TOR kinase by
rapamycin (Huang et al., 2004) and fail to resume growth
after rapamycin is removed. This latter function is depen-
dent on the EGO complex (exit from rapamycin-induced
growth arrest), which likely is identical to the GSE com-
plex since it contains most of the same subunits as the
GSE complex (Dubouloz et al., 2005).
How the GSE promotes exit of Gap1 from endosomes
is unclear, but there are at least two possibilities. The
first is that the GSE may control the formation of specific
transport vesicles at the endosome that can specifically
capture a selective set of cargo, including Gap1. Com-
ponents of the GSE itself might form the actual coat,
or alternatively the GTPase components of the GSE
might work similarly to other GTPases such as Sar1
and Arf to nucleate coat formation (Gao and Kaiser,
2006). In this regard, it is tantalizing that there is some
indication that the Gse2/Meh1/Ego1 component inter-
acts with Sec27, a component of the COP1/coatomer
complex, which in turn is implicated in budding events
within the endocytic pathway (Gu and Gruenberg,
1999; Ho et al., 2002). Another possibility is that GSE
may antagonize the sorting of Gap1 into the MVB path-
way directly. This could be accomplished by promoting
Gap1 deubiquitination at the endosome or by dampen-
ing the ability of endosomal ubiquitin binding ESCRT
complexes (endosomal sorting complex required for
transport) to bind and retain Gap1 at the endosome.
Whatever the molecular mechanism is for how the
GSE/EGO complex functions to deliver Gap1 to the
cell surface, it appears to be functionally conserved
across kingdoms. This was nicely demonstrated by
showing that expression of the mouse homolog of Gtr1,
Rag A/RRAG A, locked in its GTP bound conformation
could substitute for endogenous yeast Gtr1 (Gao and
Kaiser, 2006). Exactly which functions in mammalian
cells might be similar to the control of Gap1 exit from
yeast late endosomes is not yet clear, but they are likelyto represent key metabolic processes tied somehow to
the TOR kinase signaling pathway. One analogous func-
tion may be to play a role in how nutrient transporters are
sustained on the plasma membrane of animal cells. Re-
cent studies have shown that removal of growth factors
from cells quickly induces the clearance of nutrient
transporters from the cell surface and their degradation
in lysosomes (Edinger, 2005). This can be prevented by
inhibiting Rab7, suggesting that a key point of regulation
for this process occurs in endosomal compartments.
This process can also be prevented by activated forms
of TOR kinase, as well as activated Akt/PKB, which
lies within the TOR kinase signaling pathway and thus
provides a strong parallel to the function of GSE in yeast.
Regardless of whether this or another process is medi-
ated by the GSE complex in animal cells, elucidating
the molecular mechanisms that drive its function in
yeast should also once again show us an elegant pro-
cess for how cells manage nutrient homeostasis.
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